S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Buzz Health Wins Bronze Stevie for RxCompare Cost-Saving Tech

A Florida-based healthcare firm has secured a Bronze Stevie Award for its RxCompare platform, a technology that automates real-time prescription price comparisons. By leveraging its SmartBIN routing engine, the system scans multiple providers to deliver the lowest drug costs to pharmacy counters in under two seconds.

Buzz Health Wins Bronze Stevie for RxCompare Cost-Saving Tech
Photo: Bio & News

The 2026 Stevie Awards for Technology Excellence recognized Buzz Health in the Digital Health & Health IT Providers category, highlighting the company’s push to modernize a traditionally static prescription process. Before this development, patients often faced unpredictable out-of-pocket expenses, relying on manual card selection to find discounts. The SmartBIN engine shifts this burden by querying participating providers simultaneously and routing claims based on client-defined rules.

Currently, the system processes transactions in an average of 1.1 seconds, marking a 35% performance increase since its launch. Operating across 12,000 retail pharmacies, the platform has facilitated over $3.5 billion in savings to date. According to Raj Ramaswamy, Chief Technology Officer at Buzz Health, the core challenge involved engineering the architecture to handle variable response times from different partners without delaying the patient at the point of sale. The company has filed for patent protection on the technology, which maintains a 99.9% accuracy rate in price verification.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!